Novavax to Present at the Stifel 2017 Healthcare Conference

GAITHERSBURG, Md., Nov.  08, 2017  (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference.

Presentation details are as follows:

Date: Wednesday, November 15, 2017
Time: 1:15 p.m. - 1:55 p.m. ET
Location: Garrison, 5^th Floor, Lotte New York Palace Hotel, New York City
Live webcast: www.novavax.com, "Investors"/"Events"

A replay of the presentation will also be accessible under the "Investors/Events" section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
ir@novavax.com 
240-268-2000

Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506

Media
Russo Partners, LLC
David Schull
Maggie Beller
david.schull@russopartnersllc.com
maggie.beller@russopartnersllc.com
212-845-4271

More From BioPortfolio on "Novavax to Present at the Stifel 2017 Healthcare Conference "

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications